搜索
1

1

News Center
Homepage
/
Milestones
06-14

2022.3

Biosafety Level 2 (BSL-2) Laboratories Certificated
2022.3
02-21

2021.6

Obtained ISO13485 quality management system certification
2021.6
02-21

2020.7

Completed Series A financing
2020.7
02-21

2019.4

Establishment of Nanobody and Recombinant Antibody Platform
2019.4
02-21

2018.5

Establishment of chemiluminescence technology platform
Establishment of mammalian cell expression platforms
2018.5
02-21

2017.8

Establishment of fluorescent POCT and molecular diagnostic technology platforms
Passed the "National High-tech Enterprise" certification
Passed the "Shenzhen High-tech Enterprise" certification
2017.8
02-21

2016.6

Establish a monoclonal antibody production platform
2016.6
02-21

2015.1

Establishment of colloidal gold chromatography and enzyme-linked immunosorbent technology platform
2015.1
02-21

2014.4

The company was established, and three technology platforms of genetic engineering, protein engineering and antibody engineering were established
2014.4
Previous page
1

Shenzhen AIVD Biotechnology Co. , LTD.

A4 Building 4th Floor / B5 Building C501, China Merchants Bright Technology Park, Fenghuang Street, Guangming District, Shenzhen, Guangdong Province, China

E-mail： market@aivdbiotech.com  
             info@aivdbiotech.com

Tel： +86-755-26165742   +86 18543132823

WhatsApp：+86 18543132823

facebook facebook facebook facebook facebook

© 2022 Shenzhen AIVD Biotechnology Co.,LTD.      粤ICP备18093805号